The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnglo American Regulatory News (AAL)

Share Price Information for Anglo American (AAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,642.50
Bid: 2,910.00
Ask: 2,338.00
Change: -107.50 (-3.91%)
Spread: -572.00 (-19.656%)
Open: 2,740.00
High: 2,786.00
Low: 2,618.00
Prev. Close: 2,750.00
AAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

10 Sep 2020 15:00

RNS Number : 6541Y
Anglo American PLC
10 September 2020
 

Anglo American plc (the "Company")

Registered office: 20 Carlton House Terrace, London SW1Y 5AN

Registered number: 3564138 (incorporated in England and Wales)

Legal Entity Identifier: 549300S9XF92D1X8ME43

 

 

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.NOT AN OFFER FOR SALE OF SECURITIES

 

10 September 2020

 

These websites are not provided for, or directed at, U.S. persons or persons in the United States. If you are a U.S. person or are viewing this page from the United States, you should not access these websites.

 

RNS PUBLICATION FORM

 

Publication of Prospectus

 

Anglo American plc (the "Company") announces that the Prospectus of its subsidiary, Anglo American Capital plc, dated 10 September 2020 (the "Prospectus") relating to the US$1,000,000,000 2.625% Senior Notes due 2030 and the US$500,000,000 3.950% Senior Notes due 2050 guaranteed by the Company, has been approved by the UK Financial Conduct Authority and was published on the London Stock Exchange's website.

 

To view the Prospectus, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/6541Y_1-2020-9-10.pdf

 

The full document has been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/nsm.

 

For further information, please contact:

 

Clare Davage

Deputy Company Secretary

20 Carlton House Terrace

London SW1Y 5AN

Email: cosec.admin@angloamerican.com

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries only or to certain investors only (specified in the Prospectus) and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to reading or relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are an intended addressee of the information contained therein.

 

The Notes have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or jurisdiction of the United States and may not be offered or sold within the United States, absent registration or an applicable exemption from the registration requirements of the Securities Act. This notice is not an offer of securities for sale.

 

MiFID II professionals / ECPs-only / No PRIIPs KID - Manufacturer target market (MiFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in EEA or in the UK.

 

Your right to access the Prospectus is conditional upon complying with the above requirements.

 

1. Anglo American plc - LEI 549300S9XF92D1X8ME43

2. Anglo American Capital plc - LEI TINT358G1SSHR3L3PW36

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDILBLFFBKLZBBF
Date   Source Headline
26th Apr 20233:00 pmRNSAGM address to shareholders
25th Apr 20237:00 amRNSAnglo American Production Report Q1 2023
18th Apr 20233:30 pmRNSDirector/PDMR Shareholding
18th Apr 20238:00 amRNSAnglo American sustainability performance update
18th Apr 20237:00 amRNSAnglo American secures approval for Los Bronces
12th Apr 20237:00 amRNSDe Beers' rough diamond sales cycle 3, 2023
6th Apr 20232:30 pmRNSDividend Declaration: Sterling and Euro Rates
5th Apr 20233:30 pmRNSDirector/PDMR Shareholding
4th Apr 20238:00 amRNSAnglo American partners with H2 Green Steel
3rd Apr 20231:00 pmRNSTotal Voting Rights
28th Mar 202312:00 pmRNSDirector/PDMR Shareholding
22nd Mar 202310:00 amRNSDirector/PDMR Shareholding
17th Mar 202311:00 amRNSConfirmation of post-offer intention statement
16th Mar 20232:30 pmRNSDirector/PDMR Shareholding
14th Mar 20239:00 amRNSPublication of Final Terms
10th Mar 20232:00 pmRNSDirector/PDMR Shareholding
9th Mar 20231:00 pmRNSPublication of Offering Circular
8th Mar 20237:00 amRNSDe Beers rough diamond sales cycle 2, 2023
6th Mar 20239:00 amRNSAnnual Financial Report and Notice of AGM
3rd Mar 20233:00 pmRNSDirector/PDMR Shareholding
1st Mar 20233:00 pmRNSTotal Voting Rights
28th Feb 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20238:00 amRNSAnglo American appoints Magali Anderson as NED
23rd Feb 20237:00 amRNSAnglo American FY 2022 Financial Results
21st Feb 20237:00 amRNSKumba Iron Ore annual results 2022
20th Feb 20237:00 amRNSAnglo American Platinum annual results 2022
15th Feb 20237:00 amRNSAnglo American senior leadership change - PGMs
8th Feb 20231:18 pmRNSAcquisition of minority interest in Canada Nickel
2nd Feb 20231:30 pmRNSProvisional 2023 Dividend Timetable
2nd Feb 20237:00 amRNSAnglo American Production Report Q4 2022
1st Feb 20231:30 pmRNSTotal Voting Rights
1st Feb 20237:00 amRNSDe Beers rough diamond sales cycle 1, 2023
26th Jan 20237:00 amRNSAnglo American introduces LNG vessel to fleet
17th Jan 20237:00 amRNSAppointment of Alison Atkinson GD Projects
3rd Jan 20231:00 pmRNSTotal Voting Rights
21st Dec 202212:00 pmRNSDirector/PDMR Shareholding
21st Dec 20227:00 amRNSDe Beers rough diamond sales cycle 10, 2022
19th Dec 20223:30 pmRNSDirector/PDMR Shareholding
13th Dec 20223:30 pmRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSAnglo American investors update
7th Dec 20223:00 pmRNSAnglo American combines nuGen with First Mode
1st Dec 20222:30 pmRNSTotal Voting Rights
30th Nov 20227:00 amRNSAnglo American senior leadership changes
24th Nov 20228:00 amRNSAnglo American collaborates with Aurubis
23rd Nov 20222:00 pmRNSAnglo American secures desalinated water for LB
16th Nov 20223:30 pmRNSDirector/PDMR Shareholding
16th Nov 20227:30 amRNSRenewable electricity supply for Australia ops
16th Nov 20227:00 amRNSDe Beers rough diamond sales cycle 9, 2022
1st Nov 20221:30 pmRNSTotal Voting Rights
31st Oct 202211:00 amRNSUpdate on sustainability performance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.